Maravai LifeSciences Holdings, Inc. (MRVI)
Makes chemicals and tools that scientists use to develop drugs, vaccines, and gene therapies.
$6.88+0.03%Healthcare
StockGlow Score
Bullish
BearishBullish
1 year ago+209.7%
The outlook
MRVI trades at $6.88, trading well above its 50- and 200-day moving averages. Analysts lean bullish with an average rating near "buy," though their consensus price target sits roughly 14% below the current level. The stock is positioned near its 52-week highs.
What’s behind the score
Analyst consensusBuy — 1.8 avg of 5 analysts
Price trendAbove its 50- & 200-day averages
52-week range90% of the way from its 52-week low to high
Price targetAvg target -14% vs current price
Analyst price target
~12-month · 5 analysts$5.90average target-14.2% vs now
Now $6.88
Low $5.00High $7.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$2.54B
52-wk high
$7.44
52-wk low
$1.99
50-day avg
$5.55
200-day avg
$3.96
Trailing P/E
—